Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 265–272 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Allarity Therapeutics Inc. IXEMPRA Metastatic breast cancer (mBC) Phase 2 Trial Discontinued Intravenous Oncology
Allarity Therapeutics Inc. Stenoparib in combination with temozolomide Small Cell Lung Cancer (SCLC) Phase 2 Trial Planned Oral Oncology
Allena Pharmaceuticals Inc. Reloxaliase ALLN-177 (Study 206) Primary hyperoxaluria Phase 2 Oral Genetic Disorder
Allena Pharmaceuticals Inc. Reloxaliase (ALLN-177) - (URIROX-2) Enteric Hyperoxaluria Phase 3 Oral Gastroenterology
Allena Pharmaceuticals Inc. ALLN-346-202 Gout in chronic kidney disease (CKD) Phase 2a Oral N/A
Allena Pharmaceuticals Inc. Reloxaliase (ALLN-177) - (URIROX-2) Enteric Hyperoxaluria Phase 3 Oral Gastroenterology
Allena Pharmaceuticals Inc. Reloxaliase ALLN-177 (URIROX-1) Enteric Hyperoxaluria Phase 3 Oral Gastroenterology
Allena Pharmaceuticals Inc. Reloxaliase ALLN-177 (URIROX-1) Enteric Hyperoxaluria Phase 3 Oral Gastroenterology